4.7 C
New York
Wednesday, October 28, 2026
type here...
- Advertisement -spot_img

TAG

Alnylam

Health

Brezosiran cuts Huntington protein by up to 83% in trial

Trends News Stories Editorial -
Brezosiran lowered mutant huntingtin protein by up to 83% after a single dose in an early trial, Alnylam said, with a larger study planned for 2027.

Latest news

- Advertisement -spot_img

© Trends News Stories , LLC. All rights reserved. Trends News Stories ® is a registered U.S. trademark of News Publication and Media Company.

About Us

Popular Category

Editor Picks